The Global Genome Engineering Market is anticipated to grow from USD 5.1 billion to USD 11.2 billion till the forecasting year 2027 and grow at a CAGR of 17.0% during the period of forecast 2021-2027. Genome editing is a technique for making precise alterations to a cell’s or organism’s DNA. It is used to change DNA with a cell in a precise and efficient manner. Genome editing entails using enzymes known as designed nucleases to cut specific DNA sequences. Genome editing can also be used to remove, add, or change DNA in the genome, and it is commonly employed in research and treatment. AIDS, leukaemia, and numerous viral and genetic illnesses are among the therapy conditions. Gene editing is another name for genome engineering. Homologous recombination is anticipated to be utilized as an efficient technology for crop improvement. Increase in the number of genomics projects and government funding facilities will drive the market growth. High price of genome engineering therapies is anticipated to hit the growth of genome engineering market during the forecast period particularly in rising countries such as South Africa, India and Brazil. This therapy involves using a complex technology and requires expert researchers, which in turn limit the market growth. Several notable development are observed in the genome engineering market as companies have adopted crucial strategies like collaboration, partnership, agreement and acquisition. Key players have also adopted some crucial strategies like approvals, product expansion and product launch, which allows them to maintain their position in the market and also increase their overall customer base. Growth factors driving the genome editing market in upcoming days are increase in funds by government in different regions, government support for the academic institutes to increase research activities for genome editing and huge increase in funding. Increasing cancer cases, growth of pharmaceutical companies, fast advancements and increase in public sector funding are some significant factors boost the genome engineering market.